Cytokinetics Inc. buy Morgan Stanley
Start price
22.12.25
/
50%
€56.00
Target price
22.12.26
-
Performance (%)
-5.36%
Price
02.03.26
€53.00
Summary
This prediction is currently active. With a performance of -5.36%, the BUY prediction for Cytokinetics Inc. by Morgan_Stanley is down slightly. This prediction currently runs until 22.12.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -8.621% | -8.621% |
| iShares Core DAX® | -1,31 % | -0,78 % |
| iShares Nasdaq 100 | 1,98 % | -2,04 % |
| iShares Nikkei 225® | 0,59 % | 6,71 % |
| iShares S&P 500 | 1,42 % | -0,48 % |
Comments by Morgan_Stanley for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Morgan_Stanley for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€41.00
13.02.25
13.02.25
€64.45
13.02.26
13.02.26
35.37%
14.02.26
14.02.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€30.20
04.08.23
04.08.23
€54.39
04.08.24
04.08.24
67.22%
05.08.24
05.08.24